Related Experiment Video
Updated: Jul 9, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Forkhead box protein 3: essential immune regulatory role
Nasim Nik Tavakoli1, Brett D Hambly, David R Sullivan
1Discipline of Pathology, School of Medical Sciences and Bosch Institute, University of Sydney, New South Wales 2006, Australia.
Regulatory T (Treg) cells, marked by Foxp3, are vital for self-tolerance and preventing autoimmune diseases. Emerging research highlights their new anti-atherogenic role, offering therapeutic potential for atherosclerosis.
Area of Science:
- Immunology
- Molecular Biology
- Cardiovascular Research
Background:
- CD4+CD25+ regulatory T (Treg) cells are critical for maintaining self-tolerance and preventing autoimmune conditions.
- The transcription factor forkhead box protein 3 (Foxp3) serves as a key molecular marker for Treg cells.
- Foxp3 expression is influenced by various signaling pathways and is essential for Treg cell development and function.
Purpose of the Study:
- To summarize the established role of Treg cells and Foxp3 in autoimmunity.
- To highlight the emerging understanding of Treg cells and Foxp3 in the context of atherosclerosis.
- To explore the therapeutic implications of these findings for managing atherosclerosis.
Main Methods:
- Review of existing literature on Treg cells, Foxp3, autoimmunity, and atherosclerosis.
- Analysis of genetic studies linking Foxp3 mutations to autoimmune diseases.
- Synthesis of recent findings on the anti-atherogenic properties of Treg cells.
Main Results:
- Foxp3 is indispensable for Treg cell function and mutations lead to severe autoimmune disorders like IPEX syndrome.
- Treg cells and Foxp3 have demonstrated a significant and previously unrecognized anti-atherogenic role.
- These findings suggest a novel therapeutic strategy for atherosclerosis.
Conclusions:
- Treg cells and their marker Foxp3 are central to immune homeostasis and have implications beyond autoimmunity.
- The anti-atherogenic function of Treg cells presents a promising new avenue for cardiovascular disease treatment.
- Further research into Foxp3-targeted therapies could revolutionize atherosclerosis management.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Master Transcription Regulators
Master Transcription Regulators
General Transcription Factors
Regulation of the Unfolded Protein Response
